HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)
Award amountNot stated
Grants for phase i clinical testing
Records whose stated use of funds is Phase I clinical testing, exactly as the source published it.
Records linked3In this slice
Median award ceilingNot linked yetComputed from 0 of 3 records with a stated ceiling
Award ceiling rangeNot linked yetLowest stated floor to highest stated ceiling
Program pools (total)$11,000,000Sum of programme totals across 1 records. Not an amount any applicant receives.
Next linked deadlines
2 of 3 records carry a stated deadline; 0 are rolling and the rest read Not stated.
Funder type distribution
Federal3
Counted from linked records only.
Displaying 1 – 3 of 3
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development
Award amountNot stated
Other applicant types
Related industries
Other funding levels
Applicant type in a state
Elsewhere in the library